In 2023, the actual import value of Streptomycins to Italy was recorded at 2.038 million US dollars. The forecasted data for 2024-2028 indicates a steady increase in the import value, with a year-on-year growth of roughly 1.2% to 1.5%. From 2024 to 2028, the Compound Annual Growth Rate (CAGR) is projected at approximately 1.1%. These continuous increases suggest a consistent demand for Streptomycins in Italy, reflecting both the medical sector’s reliance on this antibiotic and the general expansion of pharmaceutical imports in Italy.

Future trends to observe include:

Changes in regulatory policies affecting pharmaceutical imports.
Potential shifts in global Streptomycin supply or pricing due to geopolitical or economic factors.
Advancements in alternative antibiotics which could impact demand trajectories.